AIM IMMUNOTECH INC. Proceeds From Sale Of Equity Securities Fv Ni
AIM IMMUNOTECH INC. (AIM) reported Proceeds From Sale Of Equity Securities Fv Ni of $4.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi · last filed 2026-08-07
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for the quarter ending 2026-03-31 was $4.00K, a 99.62% decline year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for the quarter ending 2025-06-30 was $981.00K.
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for the quarter ending 2025-03-31 was $1.04M.
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for fiscal 2025 was $2.32M, a 58.71% decline from fiscal 2024.
- AIM IMMUNOTECH INC. proceeds from sale of equity securities fv ni for fiscal 2024 was $5.62M.
| Period end | Proceeds From Sale Of Equity Securities Fv Ni 3 month | Proceeds From Sale Of Equity Securities Fv Ni 6 month | Proceeds From Sale Of Equity Securities Fv Ni 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $2.32M 10-K · filed 2026-03-27 | ||
| 2025-06-30 | $981.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.03M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $1.04M 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $5.62M 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |